Revised SPC: Modigraf (tacrolimus) 0.2mg & 1mg granules for oral suspension -

Revised SPC: Modigraf (tacrolimus) 0.2mg & 1mg granules for oral suspension
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Cardiovascular system disorders | Liver disorders | Renal and urologic disorders | Surgery
Summary
Information on potential for gastrointestinal perforation in patients treated with tacrolimus has been added to SPC as has rare reports of QT prolongation and ‘Torsades de Pointes’.
UKMi comment
The SPC for Advagraf 0.5mg, 1mg, 3mg and 5mg Prolonged-release hard capsules have also been updated with this information.
Related links: Link to Advagraf SPC